The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
Open accessAbstract
Currently there is no established guidance on how to process and evaluate resected lung cancer specimens following neoadjuvant therapy in the setting of clinical trials and clinical practice. There is also a lack of precise definitions on the degree of pathologic response, including major pathologic response (MPR) or complete pathologic response (CPR). In other cancers such as osteosarcoma, colorectal, breast and esophageal carcinomas, there have been multiple studies investigating pathologic assessment of the effects of neoadjuvant therapy including some detailed recommendations on how to handle these specimens. A comprehensive mapping approach to gross and histologic processing of osteosarcomas following induction therapy has been used for over 40 years. The purpose of this article is to outline detailed recommendations on how to process lung cancer resection specimens and to define pathologic response including MPR and CPR following neoadjuvant therapy. A standardized approach is recommended to assess the percentages of: 1) viable tumor, 2) necrosis and 3) stroma (including inflammation and fibrosis) with a total adding up to 100%. This is recommended for all systemic therapies including chemotherapy, chemoradiation, molecular targeted therapy, immunotherapy or any future novel therapies yet to be discovered whether administered alone or in combination. Specific issues may differ for certain therapies such as immunotherapy, but the grossing process should be similar and the histologic evaluation should contain these basic elements. Standard pathologic response assessment should allow for comparisons between different therapies and correlations with disease free survival and overall survival in ongoing and future trials. The International Association for the Study of Lung Cancer (IASLC) has an effort to collect such data from existing and future clinical trials. These recommendations are intended as guidance for clinical trials, although it is hoped they can be viewed as suggestion for good clinical practice outside of clinical trials, to improve consistency of pathologic assessment of treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon, J.-P., Tribodet, H., Scagliotti, G. V., Douillard, J.-Y., Shepherd, F. A., Stephens, R. J., Dunant, A., Torri, V., Rosell, R., Seymour, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9030 · Cited by 2,642
Self-citationGianni, L., Pienkowski, T., Im, Y.-H., Roman, L., Tseng, L.-M., Liu, M.-C., Lluch, A., Staroslawska, E., de la Haba-Rodriguez, J., Im, S.-A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70336-9 · Cited by 2,374
Postmus, P. E., Kerr, K. M., Oudkerk, M., Senan, S., Waller, D. A., Vansteenkiste, J., Escriu, C., & Peters, S. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx222 · Cited by 2,302
Self-citationNeoadjuvant PD-1 Blockade in Resectable Lung Cancer
Forde, P. M., Chaft, J. E., Smith, K. N., Anagnostou, V., Cottrell, T. R., Hellmann, M. D., Zahurak, M., Yang, S. C., Jones, D. R., Broderick, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716078 · Cited by 2,099
Self-citationLindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
Self-citationYoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Self-citationGianni, L., Pienkowski, T., Im, Y.-H., Tseng, L.-M., Liu, M.-C., Lluch, A., Starosławska, E., de la Haba-Rodriguez, J., Im, S.-A., Pedrini, J. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00163-7 · Cited by 880
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Self-citationTravis, W. D., Asamura, H., Bankier, A. A., Beasley, M. B., Detterbeck, F., Flieder, D. B., Goo, J. M., MacMahon, H., Naidich, D., Nicholson, A. G., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.03.025 · Cited by 722
Self-citationHellmann, M. D., Chaft, J. E., William, W. N., Rusch, V., Pisters, K. M. W., Kalhor, N., Pataer, A., Travis, W. D., Swisher, S. G., & Kris, M. G. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70334-6 · Cited by 646
Self-citationLindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.001 · Cited by 645
Self-citationCottrell, T. R., Thompson, E. D., Forde, P. M., Stein, J. E., Duffield, A. S., Anagnostou, V., Rekhtman, N., Anders, R. A., Cuda, J. D., Illei, P. B., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy218 · Cited by 592
Self-citationBetticher, D. C., Hsu Schmitz, S.-F., Tötsch, M., Hansen, E., Joss, C., von Briel, C., Schmid, R. A., Pless, M., Habicht, J., Roth, A. D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.040 · Cited by 449
Self-citationAg, H., Rosen, G., & Marcove, R. C. (1977) · PubMed · Cited by 396
Pataer, A., Kalhor, N., Correa, A. M., Raso, M. G., Erasmus, J. J., Kim, E. S., Behrens, C., Lee, J. J., Roth, J. A., Stewart, D. J., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318247504a · Cited by 374
Self-citationPrognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer
Brambilla, E., Le Teuff, G., Marguet, S., Lantuejoul, S., Dunant, A., Graziano, S., Pirker, R., Douillard, J.-Y., Le Chevalier, T., Filipits, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0970 · Cited by 349
Self-citationPrognostic implications of fibrotic focus (scar) in small peripheral lung cancers
Shimosato, Y., Hashimoto, T., Kodama, T., Kameya, T., Suzuki, A., Nishiwaki, Y., & Yoneyama, T. (1980) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198008000-00005 · Cited by 280
Zhong, W.-Z., Chen, K.-N., Chen, C., Gu, C.-D., Wang, J., Yang, X.-N., Mao, W.-M., Wang, Q., Qiao, G.-B., Cheng, Y., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00075 · Cited by 268
Mauguen, A., Pignon, J.-P., Burdett, S., Domerg, C., Fisher, D., Paulus, R., Mandrekar, S. J., Belani, C. P., Shepherd, F. A., Eisen, T., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70158-x · Cited by 246
Bossuyt, V., Provenzano, E., Symmans, W. F., Boughey, J. C., Coles, C., Curigliano, G., Dixon, J. M., Esserman, L. J., Fastner, G., Kuehn, T., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv161 · Cited by 240
Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC
Coroller, T. P., Agrawal, V., Huynh, E., Narayan, V., Lee, S. W., Mak, R. H., & Aerts, H. J. W. L. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.11.2226 · Cited by 228
Imaging of Cancer Immunotherapy: Current Approaches and Future Directions
Nishino, M., Hatabu, H., & Hodi, F. S. (2019) · Radiology · doi:10.1148/radiol.2018181349 · Cited by 211
Shia, J., Guillem, J. G., Moore, H. G., Tickoo, S. K., Qin, J., Ruo, L., Suriawinata, A., Paty, P. B., Minsky, B. D., Weiser, M. R., et al. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200402000-00009 · Cited by 199
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
Blumenthal, G. M., Bunn, P. A., Chaft, J. E., McCoach, C. E., Perez, E. A., Scagliotti, G. V., Carbone, D. P., Aerts, H. J. W. L., Aisner, D. L., Bergh, J., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.017 · Cited by 184
Self-citationNishino, M., Jagannathan, J. P., Krajewski, K. M., O’Regan, K., Hatabu, H., Shapiro, G., & Ramaiya, N. H. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7483 · Cited by 180
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Stein, J. E., Lipson, E. J., Cottrell, T. R., Forde, P. M., Anders, R. A., Cimino-Mathews, A., Thompson, E. D., Allaf, M. E., Yarchoan, M., Feliciano, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2379 · Cited by 177
Grading of Tumor Regression in Non-small Cell Lung Cancer
Junker, K., Langner, K., Klinke, F., Bosse, U., & Thomas, M. (2001) · Chest · doi:10.1378/chest.120.5.1584 · Cited by 176
Kadota, K., Suzuki, K., Kachala, S. S., Zabor, E. C., Sima, C. S., Moreira, A. L., Yoshizawa, A., Riely, G. J., Rusch, V. W., Adusumilli, P. S., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.58 · Cited by 174
Self-citationJunker, K., Thomas, M., Schulmann, K., Klinke, F., Bosse, U., & M�ller, K. M. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01192200 · Cited by 174
Wakelee, H. A., Dahlberg, S. E., Keller, S. M., Tester, W. J., Gandara, D. R., Graziano, S. L., Adjei, A. A., Leighl, N. B., Aisner, S. C., Rothman, J. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30691-5 · Cited by 171
Parra, E. R., Villalobos, P., Behrens, C., Jiang, M., Pataer, A., Swisher, S. G., William, W. N., Zhang, J., Lee, J., Cascone, T., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0368-0 · Cited by 167
Self-citationThe Tumor Microenvironment in Non–Small-Cell Lung Cancer
Graves, E. E., Maity, A. M., & Le, Q. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.01.003 · Cited by 157
Kwiatkowski, D. J., Rusch, V. W., Chaft, J. E., Johnson, B. E., Nicholas, A., Wistuba, I. I., Merritt, R., Lee, J. M., Bunn, P. A., Tang, Y., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.8503 · Cited by 146
Self-citationCascone, T., William, W. N., Weissferdt, A., Lin, H. Y., Leung, C. H., Carter, B. W., Fossella, F. V., Mott, F. E., Papadimitrakopoulou, V. A., Blumenschein, G. R., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.8504 · Cited by 144
Self-citationWilliam, W. N., Pataer, A., Kalhor, N., Correa, A. M., Rice, D. C., Wistuba, I. I., Heymach, J., Lee, J. J., Kim, E. S., Munden, R., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182774108 · Cited by 138
Self-citationQu, Y., Emoto, K., Eguchi, T., Aly, R. G. M., Zheng, H., Chaft, J. E., Tan, K. S., Jones, D. R., Kris, M. G., Adusumilli, P. S., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.11.017 · Cited by 125
Self-citationChaft, J. E., Rusch, V., Ginsberg, M. S., Paik, P. K., Finley, D. J., Kris, M. G., Price, K. A. R., Azzoli, C. G., Fury, M. G., Riely, G. J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829923ec · Cited by 122
Self-citationXiong, L., Li, R., Sun, J., Lou, Y., Zhang, W., Bai, H., Wang, H., Shen, J., Jing, B., Shi, C., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0120 · Cited by 121
Dooms, C., Verbeken, E., Stroobants, S., Nackaerts, K., Leyn, P. D., & Vansteenkiste, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9550 · Cited by 118
Self-citationPeintinger, F., Sinn, B. V., Hatzis, C., Albarracin, C. T., Downs-Kelly, E. P., Morkowski, J., Gould, R., & Symmans, W. F. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.53 · Cited by 117
Phase II Study of Preoperative Gefitinib in Clinical Stage I Non–Small-Cell Lung Cancer
Lara-Guerra, H., Waddell, T. K., Salvarrey, A. M., Joshua, A. M., Chung, C. T. ‐., Paul, N., Boerner, S. L., Sakurada, A., Ludkovski, O., Ma, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3370 · Cited by 112
Self-citationCanter, R. J., Martinez, S. R., Tamurian, R. M., Wilton, M., Li, C., Ryu, J. K., Mak, W. H., Monsky, W. L., & Borys, D. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1156-3 · Cited by 108
de Langen, A. J., van den Boogaart, V., Lubberink, M., Backes, W. H., Marcus, J. T., van Tinteren, H., Pruim, J., Brans, B. T., Leffers, P., Dingemans, A. C., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.078261 · Cited by 101
Schaake, E. E., Kappers, I., Codrington, H., Olmos, R. A. V., Teertstra, H. J., van Pel, R., Burgers, J. A., van Tinteren, H., & Klomp, H. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4882 · Cited by 99
Zhang, C., Li, S., Nie, Q., Dong, S., Shao, Y. W., Yang, X., Wu, Y.-L. L. C., Yang, Y., & Zhong, W. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.10.161 · Cited by 98
Ali, H. R., Dariush, A., Provenzano, E., Bardwell, H. A., Abraham, J., Iddawela, M. Y., Vallier, A.-L., Hiller, L., Dunn, J., Bowden, S. J., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0682-8 · Cited by 95
Convolutional Neural Network for Histopathological Analysis of Osteosarcoma
Mishra, R., Daescu, O., Leavey, P. J., Rakheja, D., & Sengupta, A. L. (2017) · Journal of Computational Biology · doi:10.1089/cmb.2017.0153 · Cited by 89
Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma
Weichert, W., Kossakowski, C. A., Harms, A., Schirmacher, P., Muley, T., Dienemann, H., & Warth, A. (2015) · European Respiratory Journal · doi:10.1183/13993003.00937-2015 · Cited by 84
Rizvi, N. A., Rusch, V. W., Pao, W. J., Chaft, J. E., Ladanyi, M., Miller, V. A., Krug, L. M., Azzoli, C. G., Bains, M. S., Downey, R. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2102 · Cited by 70
Self-citationFibrous Stroma Is Associated with Poorer Prognosis in Lung Squamous Cell Carcinoma Patients
Takahashi, Y., Ishii, G., Taira, T., Fujii, S., Yanagi, S., Hishida, T., Yoshida, J., Nishimura, M., Nomori, H., Nagai, K., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318229189d · Cited by 69
Yamane, Y., Ishii, G., Goto, K., Kojima, M., Nakao, M., Shimada, Y., Nishiwaki, Y., Nagai, K., Kohrogi, H., & Ochiai, A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c0a1f8 · Cited by 62
Immunotherapy in surgically resectable non-small cell lung cancer
Owen, D. H., & Chaft, J. E. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.12.93 · Cited by 58
Self-citationPartial regression in primary carcinoma of the lung: does it occur?
Kerr, K. M., Johnson, S. K., King, G., Kennedy, M., Weir, J., & Jeffrey, R. R. (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00453.x · Cited by 55
Self-citationHistopathologic Features of Prognostic Significance in High-Grade Osteosarcoma
Chui, M. H., Kandel, R. A., Wong, M., Griffin, A. M., Bell, R. S., Blackstein, M. E., Wunder, J. S., & Dickson, B. C. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0389-oa · Cited by 54
Poettgen, C., Theegarten, D., Eberhardt, W., Levegruen, S., Gauler, T. C., Krbek, T., Stamatis, G., Teschler, H., Kuehl, H., Bockisch, A., et al. (2007) · Oncology · doi:10.1159/000134474 · Cited by 53
Mäkinen, J. M., Laitakari, K. E. M., Johnson, S., Mäkitaro, R., Bloigu, R., Pääkkö, P. K., Lappi‐Blanco, E., & Kaarteenaho, R. L. (2017) · Histopathology · doi:10.1111/his.13236 · Cited by 49
Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC).
Shu, C. A., Grigg, C. M., Chiuzan, C. C., Garofano, R. F., Patel, V., Hernández, S., Negri, T., Sacher, A. G., Smith–Marrone, S., Stoopler, M. B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.8532 · Cited by 45
Lara-Guerra, H., Chung, C. T. ‐., Schwock, J., Pintilie, M., Hwang, D. M., Leighl, N. B., Waddell, T. K., & Tsao, M. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.10.020 · Cited by 39
Self-citationPulmonary Tuberculosis and Lung Cancer Risk in Current Smokers: The Seoul Male Cancer Cohort Study
Bae, J., Li, Z., Shin, M., Kim, D., Lee, M.-S., & Ahn, Y. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.6.896 · Cited by 36
OA13.05 NADIM Study: Updated Clinical Research and Outcomes
Provencio, M., Nadal, E., Insa, A., Campelo, R. G., Casal, J., Dómine, M., Majem, M., Rodríguez‐Abreu, D., Martínez‐Martí, A., Carpeño, J. D. C., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.480 · Cited by 36
Self-citationLee, H. Y., Lee, H. J., Kim, Y. T., Kang, C. H., Jang, B. G., Chung, D. H., Goo, J. M., Park, C. M., Lee, C. H., & Kang, K. W. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d2efe7 · Cited by 35
Self-citationInduction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
Cascone, T., Gold, K. A., Swisher, S. G., Liu, D. D., Fossella, F. V., Sepesi, B., Pataer, A., Weissferdt, A., Kalhor, N., Vaporciyan, A. A., et al. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.08.052 · Cited by 32
Self-citationWerutsky, G., a, B. H., Pinto, J. A. L. D. F., Martínez-Mesa, J., Zanini, M. L., Berdichevski, E. H., de Vilas, E. R., da Silva, V. D., Tsukazan, M. T. R., Vieira, A., et al. (2019) · BMC Cancer · doi:10.1186/s12885-018-5233-5 · Cited by 31
Standardizing of Pathology in Patients Receiving Neoadjuvant Chemotherapy
Bossuyt, V., & Symmans, W. F. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5317-x · Cited by 30
Kozak, M. M., Murphy, J. D., Schipper, M. L., Donington, J. S., Zhou, L. Y., Whyte, R. I., Shrager, J. B., Hoang, C. D., Bazan, J. G., Maxim, P. G., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821517db · Cited by 28
Bahce, I., Vos, C. G., Dickhoff, C., Hartemink, K. J., Dahele, M., Smit, E. F., Boellaard, R., Hoekstra, O. S., & Thunnissen, E. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.010 · Cited by 25
Self-citationProcessing and Reporting of Breast Specimens in the Neoadjuvant Setting
Bossuyt, V. (2017) · Surgical pathology clinics · doi:10.1016/j.path.2017.09.010 · Cited by 25
Blaauwgeers, J. L. G., Kappers, I., Klomp, H. M., Belderbos, J. S. A., Dijksman, L. M., Smit, E. F., Postmus, P. E., Paul, M. A., Oosterhuis, J. W., Hartemink, K. J., et al. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1404-6 · Cited by 22
Self-citationYe, N., Bao, M., Xiaoxia, Y., Xie, D., & Jiang, G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.06 · Cited by 20
Ong, M., Kwan, K. F., Kamel‐Reid, S., & Vincent, M. D. (2012) · Current Oncology · doi:10.3747/co.19.908 · Cited by 18
Xia, D., Casanova, R., Machiraju, D., McKee, T. D., Weder, W., Beck, A. H., & Soltermann, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-22254-4 · Cited by 17
Self-citationSepesi, B., Godoy, M., William, W., Vaporciyan, A., Lin, H., Leung, C., Lee, J., Mitchell, K., Weissferdt, A., Le, X., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.1595 · Cited by 14
Self-citationThe Perfect Pathology Report After Neoadjuvant Therapy
Marchiò, C., Maletta, F., Annaratone, L., & Sapino, A. (2015) · JNCI Monographs · doi:10.1093/jncimonographs/lgv016 · Cited by 14
Rotow, J. K., Woodard, G. A., Urisman, A., McCoach, C. E., Bivona, T. G., Elicker, B. M., Jablons, D. M., & Blakely, C. M. (2018) · Clinical Lung Cancer · doi:10.1016/j.cllc.2018.11.003 · Cited by 14
Sacher, A. G., Le, L. W., Lara-Guerra, H., Waddell, T. K., Sakashita, S., Chen, Z., Kim, L., Zhang, T., Kamel‐Reid, S., Salvarrey, A. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8350 · Cited by 12
Self-citationParikh, A. B., Hammons, L. R., & Gomez, J. E. (2019) · Anticancer Research · doi:10.21873/anticanres.13191 · Cited by 10
Cited by
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
Forde, P. M., Spicer, J., Lu, S., Provencio, M., Mitsudomi, T., Awad, M. M., Felip, E., Broderick, S. R., Brahmer, J. R., Swanson, S. J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202170 · Cited by 2,825
Self-citationProvencio, M., Nadal, E., Insa, A., García-Campelo, M. R., Casal-Rubio, J., Dómine, M., Majem, M., Rodríguez-Abreu, D., Martínez-Martí, A., De Castro Carpeño, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30453-8 · Cited by 841
Self-citationPerioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Heymach, J. V., Harpole, D., Mitsudomi, T., Taube, J. M., Galffy, G., Hochmair, M., Winder, T., Zukov, R., Garbaos, G., Gao, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304875 · Cited by 778
Self-citationGuidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Kuang, M., et al. (2023) · Liver Cancer · doi:10.1159/000530495 · Cited by 477
Self-citationLu, S., Zhang, W., Wu, L., Wang, W., Zhang, P., Neotorch Investigators, Fang, W., Xing, W., Chen, Q., Yang, L., et al. (2024) · JAMA · doi:10.1001/jama.2023.24735 · Cited by 383
Self-citation
Metadata
- Authors
- Travis, W. D., Dacic, S., Wistuba, I., Sholl, L., Adusumilli, P., Bubendorf, L., Bunn, P., Cascone, T., Chaft, J., Chen, G., Chou, T.-Y., Cooper, W., Erasmus, J. J., Ferreira, C. G., Goo, J.-M., Heymach, J., Hirsch, F. R., Horinouchi, H., Kerr, K., Kris, M., Jain, D., Kim, Y. T., Lopez-Rios, F., Lu, S., Mitsudomi, T., Moreira, A., Motoi, N., Nicholson, A. G., Oliveira, R., Papotti, M., Pastorino, U., Paz-Ares, L., Pelosi, G., Poleri, C., Provencio, M., Roden, A. C., Scagliotti, G., Swisher, S. G., Thunnissen, E., Tsao, M. S., Vansteenkiste, J., Weder, W., & Yatabe, Y.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 15
- Issue
- 5
- Pages
- 709-740
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W3003197494
- Cited by
- 465
- References
- 77
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.